Influenza outbreak

RECENT NEWS
Japan Today  Aug 28  Comment 
The Agriculture Ministry on Friday partiality lifted a ban on imports of live poultry and poultry meat from the United States and Canada following an outbreak of bird flu. Imports from the eight U.S. states of Oregon, Washington, Idaho,...
Agriculture Online  Aug 28  Comment 
The poultry industry has seen a decline in total egg production year-to-date, compared to 2014. A July USDA Chicken and Eggs report indicates that total egg production in the United States is 10% lower and layers are down 9% compared to July of...
Benzinga  Aug 11  Comment 
iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, received notice that its application for a U.S. patent for a monoclonal antibody targeting influenza is scheduled to...
newratings.com  Aug 3  Comment 
BASEL (dpa-AFX) - Swiss drug maker Novartis AG (NVS) announced that it has completed the divestiture of its influenza vaccines business, including influenza vaccines development pipeline, to Australian specialty biopharmaceutical company CSL Ltd....
Benzinga  Aug 2  Comment 
CSL Limited acquired influenza vaccines business of Novartis (NYSE: NVS), including influenza vaccines development pipeline Basel, Switzerland, August 3, 2015 - Novartis today announced that it has completed effective July 31, 2015 the...
Insurance Journal  Jul 30  Comment 
The federal government expects to spend $191 million to pay chicken and turkey farmers for birds lost to avian flu. U.S. Secretary of Agriculture Tom Vilsack says that’s in addition to the nearly $400 million spent on cleaning up dead … The...
Insurance Journal  Jul 24  Comment 
Scientists have developed a vaccine strain that has tested 100 percent effective in protecting chickens from bird flu and testing is underway to see if it also protects turkeys, U.S. Agriculture Secretary Tom Vilsack told the House Agriculture...
The Hindu Business Line  Jul 22  Comment 
Though a temporary phenomenon, this could help domestic players re-visit their traditional markets
GenEng News  Jul 22  Comment 
While many of us are spending the last half of the summer deciding where the nicest beaches are and who makes the best island cocktails, infectious disease scientists are looking ahead toward the next inevitable outbreak of the flu. Influenza...
Agrimoney.com  Jul 20  Comment 
Cal-Maine Foods unveils a large rise in profits - but not one as big as expected by investors after the spurt to egg prices from bird flu




 
TOP CONTRIBUTORS

Influenza, or the flu, is a common infectious disease, which can be deadly to individuals with compromised immune systems (the very young, the very old, and those with conditions such as AIDS or Cancer). However, occasionally particularly virulent strains of influenza break out that can be threatening on a much larger scale -- such as the flu epidemic of 1918 and, more recently, concerns that H5N1 "Bird Flu" or H1N1 "Swine Flu" could mutate into a highly-infectious and deadly virus. A number of pharmaceutical companies make treatments for the flu and benefit from the fear of a flu outbreak.


  • Roche Pharmaceuticals makes Tamiflu, an antiviral pill to treat the flu. In 2005, amid concerns that bird flu might pose a large threat during the winter flu season, many national governments began stocking up on Tamiflu. Chugai pharmaceuticals sells Tamiflu in Japan.
  • Novartis AG (NVS), through its acquisition of Chiron in 2006, supplies much of the traditional flu vaccine supply to the United States.
  • AstraZeneca (AZN), through recently acquired MedImmune, manufactures 'FluMist', a novel flu vaccine that is delivered via an intranasal spray rather than via an injection.

Companies with treatments for H1N1, or "Swine Flu"

In April 2009, a novel flu virus, known as "Swine Flu" because it was believed to have originated in pigs, started infecting humans. By April 28th, there were 1,300 confirmed cases of the flu, known by its scientific designation H1N1, in Mexico, and a handful in the U.S. and other parts of the world.

According to preliminary test done by the US Center for Disease Control, Roche Pharmaceuticals (RHHBY)'s Tamiflu and GlaxoSmithKline (GSK)'s Relenza are active against H1N1, although many older drugs are not. [1]

References

  1. Investors buy up shares of flu drug makers, New York Times, April 27th 2009.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki